Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 20|pp. 23810–23830
CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer
Back to articleFigure 7(7 of 8)
100%
Figure 7
Figure 7.Kaplan-Meier analyses indicate that patients in low risk group have better OS than those in high risk group (blue represents low risk group and yellow represents high risk group, Logrank p < 0.0001).